ERBB2 and neoplasm: For tumor pathologic response prediction, the addition of luminal A, luminal B, HER2 and basal-like tumors generated AUCs of 0.954, 0.934, 0.952 and 0.950, while for tumor clinical response prediction, the AUCs were 0.948, 0.926, 0.913 and 0.914, respectively.